6:11 PM
Sep 25, 2013
 |  BC Extra  |  Financial News

ADMA amends IPO

ADMA Biologics Inc. (Hackensack, N.J.) again amended its IPO and now plans to sell 2.7 million shares at $8.50-$9.50. At the $9 midpoint, the company would raise $24 million and be valued at $76.8 million. In additional to Oppenheimer...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >